By Corinne Purtill Maureen Miller, an infectious disease epidemiologist and medical anthropologist at Columbia University, was not surprised to learn this week that an Italian greyhound in Paris had become the first dog known to catch monkeypox from a human. The U.S....
By Sarah Knapton Britain is in the grip of a new silent health crisis. For 14 of the past 15 weeks, England and Wales have averaged around 1,000 extra deaths each week, none of which are due to Covid. If the current trajectory continues, the number of...
By Erika Edwards and Laura Strickler COVID-19’s omicron variant appears to be affecting children under age 5 in a new way: a harsh, barking cough known as croup. While croup generally is not harmful, it can be frightening for parents already on edge about...
By Sarah Al-Arshani Public health experts have previously said vaccine inequality would allow for new variants. A Texas doctor and his team developed Corbevax, a low-cost COVID-19 vaccine. The vaccine just received emergency use authorization in India. A Texas...
By CARLA K. JOHNSON A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus. Researchers tested the pill used for depression and...
By Mike Bebernes What’s happening The number of Americans quitting their jobs has hit record highs over the past several months in a phenomenon economists have been calling the “Great Resignation.” In August, 4.3 million U.S. workers — almost 3 percent of...
By Jessica Bernard, Associate Professor, Texas A&M University With more than 18 months of the pandemic in the rearview mirror, researchers have been steadily gathering new and important insights into the effects of COVID-19 on the body and brain. These...